search
Back to results

Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index

Primary Purpose

Ulcer, Gastric, Bile Reflux

Status
Unknown status
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
fibrogastroscopy, biopsy of the gastric mucosa, microscopy biopsy materials, using Bile Reflux Index
Sponsored by
Private Healthcare Institution Clinical Hospital RGD-Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Ulcer, Gastric

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • morbid obesity
  • BMI above 35 kg/m2 with obesity related comorbidity
  • BMI above 40 kg/m2
  • undergoing MGB/OAGB
  • no bile reflux during preoperative period

Exclusion Criteria:

  • revisional operations
  • therapy-resistant bile reflux during preoperative period
  • history of bariatric surgery

Sites / Locations

  • Private Healthcare Institution Clinical Hospital "RGD-Medicine" Rostov-on-Don"Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

hand-sewn gastroenteroanastomosis

stapler gastroenteroanastomosis

Arm Description

Outcomes

Primary Outcome Measures

Success
Determination of the BRI index in patients undergoing MGB/OAGB can be used as a screening method for diagnosing biliary reflux in order to prevent and develop tactic for further management of patients from a risk group of complications associated with the toxic effects of an aggressive bile

Secondary Outcome Measures

Full Information

First Posted
April 10, 2021
Last Updated
April 10, 2021
Sponsor
Private Healthcare Institution Clinical Hospital RGD-Medicine
search

1. Study Identification

Unique Protocol Identification Number
NCT04845438
Brief Title
Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index
Official Title
Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Unknown status
Study Start Date
December 29, 2020 (Actual)
Primary Completion Date
November 1, 2021 (Anticipated)
Study Completion Date
March 8, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Private Healthcare Institution Clinical Hospital RGD-Medicine

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
MGB is considered to be the best alternative to Roux-en-Y gastric bypass (RYGB) due to the shorter operation time and fewer possible complications. The purpose of this study was to determine biliary reflux in patients undergoing MGB/OAGB with a hand-sewn gastroenteroanastomosis, and MGB/OAGB with a stapler gastroenteroanastomosis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcer, Gastric, Bile Reflux

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Non-Randomized
Enrollment
122 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
hand-sewn gastroenteroanastomosis
Arm Type
Active Comparator
Arm Title
stapler gastroenteroanastomosis
Arm Type
Active Comparator
Intervention Type
Diagnostic Test
Intervention Name(s)
fibrogastroscopy, biopsy of the gastric mucosa, microscopy biopsy materials, using Bile Reflux Index
Intervention Description
fibrogastroscopy, biopsy of the gastric mucosa, microscopy biopsy materials, using Bile Reflux Index
Primary Outcome Measure Information:
Title
Success
Description
Determination of the BRI index in patients undergoing MGB/OAGB can be used as a screening method for diagnosing biliary reflux in order to prevent and develop tactic for further management of patients from a risk group of complications associated with the toxic effects of an aggressive bile
Time Frame
12 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: morbid obesity BMI above 35 kg/m2 with obesity related comorbidity BMI above 40 kg/m2 undergoing MGB/OAGB no bile reflux during preoperative period Exclusion Criteria: revisional operations therapy-resistant bile reflux during preoperative period history of bariatric surgery
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Arut Mezhunts
Phone
89885637263
Email
arut.mezhunts@mail.ru
Facility Information:
Facility Name
Private Healthcare Institution Clinical Hospital "RGD-Medicine" Rostov-on-Don"
City
Rostov-on-Don
ZIP/Postal Code
344010
Country
Russian Federation
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Arut Mezhunts
Phone
89885637263

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of Biliary Reflux After Mini-gastric Bypass With Using the Biliary Reflux Index

We'll reach out to this number within 24 hrs